Single-tube multiplex PCR using type-specific E6/E7 primers and capillary electrophoresis genotypes 21 human papillomaviruses in neoplasia

Infectious Agents and Cancer

Volumn 6, Issue 1, 2011, Pages

  Dictor, Michael ^a   Warenholt, Janina ^a  

^a Lund University   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

OLIGONUCLEOTIDE;

ADENOCARCINOMA; ARTICLE; CAPILLARY ELECTROPHORESIS; CONTROLLED STUDY; GENOTYPE; HUMAN; HUMAN CELL; LYMPH NODE METASTASIS; MULTIPLEX POLYMERASE CHAIN REACTION; NONHUMAN; NUCLEOTIDE SEQUENCE; PLASMID; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; UTERINE CERVIX CANCER; VALIDATION PROCESS; VIRUS DETECTION; VIRUS GENE; VIRUS ONCOGENE; WART VIRUS;

EID: 78651405827     PISSN: None     EISSN: 17509378     Source Type: Journal    
DOI: 10.1186/1750-9378-6-1     Document Type: Article

References (29)

1. Rapid detection of human papillomavirus in cervical scrapes by combined general primer-mediated and type-specific polymerase chain reaction. AJ van den Brule CJ Meijer V Bakels P Kenemans JM Walboomers, J Clin Microbiol 1990 28 2739 2743 2177751
2. Cervical human papillomavirus screening by PCR: advantages of targeting the E6/E7 region. BJ Morris, Clin Chem Lab Med (Pubitemid 41600666)
3. Structural and transcriptional analysis of human papillomavirus type 16 sequences in cervical carcinoma cell lines. CC Baker WC Phelps V Lindgren MJ Braun MA Gonda PM Howley, J Virol 1987 61 962 971 3029430 (Pubitemid 17044004)
4. Systematic review of genomic integration sites of human papillomavirus genomes in epithelial dysplasia and invasive cancer of the female lower genital tract. N Wentzensen S Vinokurova M von Knebel Doeberitz, Cancer Res 2004 64 3878 3884 10.1158/0008-5472.CAN-04-0009 15172997 (Pubitemid 38697299)
5. The E7 oncoprotein is translated from spliced E6*I transcripts in high-risk human papillomavirus type 16- or type 18-positive cervical cancer cell lines via translation reinitiation. S Tang M Tao JP McCoy ZM Zheng, J Virol 2006 80 4249 4263 10.1128/JVI.80.9.4249-4263.2006 16611884
6. Development of a sensitive and specific assay combining multiplex PCR and DNA microarray primer extension to detect high-risk mucosal human papillomavirus types. T Gheit S Landi F Gemignani PJ Snijders S Vaccarella S Franceschi F Canzian M Tommasino, J Clin Microbiol 2006 44 2025 2031 10.1128/JCM.02305-05 16757593 (Pubitemid 43902148)
7. Simultaneous amplification and identification of 25 human papillomavirus types with Templex technology. J Han DC Swan SJ Smith SH Lum SE Sefers ER Unger YW Tang, J Clin Microbiol 2006 44 4157 4162 10.1128/JCM.01762-06 17005760 (Pubitemid 44737263)
8. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Munoz FX Bosch S de Sanjose R Herrero X Castellsague KV Shah PJ Snijders CJ Meijer, N Engl J Med 2003 348 518 527 10.1056/NEJMoa021641 12571259 (Pubitemid 36159887)
9. Comparative analysis of 19 genital human papillomavirus types with regard to p53 degradation, immortalization, phylogeny, and epidemiologic risk classification. T Hiller S Poppelreuther F Stubenrauch T Iftner, Cancer Epidemiol Biomarkers Prev 2006 15 1262 1267 10.1158/1055-9965.EPI-05-0778 16835321 (Pubitemid 44125279)
10. Results of the first World Health Organization international collaborative study of detection of human papillomavirus D0A. WG Quint SR Pagliusi N Lelie EM de Villiers CM Wheeler, J Clin Microbiol 2006 44 571 579 10.1128/JCM.44.2.571-579.2006 16455914 (Pubitemid 43222253)
11. Multiplex polymerase chain reaction on FTA cards vs. flow cytometry for B-lymphocyte clonality. M Dictor I Skogvall J Warenholt E Rambech, Clin Chem Lab Med 2007 45 339 345 10.1515/CCLM.2007.049 17378729 (Pubitemid 46486615)
12. Summary report on HPV and cervical cancer statistics in Sweden. WHO/ICO Information Centre on HPV and Cervical Cancer 2007 http://www.who.int/hpvcentre
13. Human papillomavirus (HPV) in head and neck cancer. S Syrjanen, J Clin Virol 2005 32 Suppl 1 59 66 10.1016/j.jcv.2004.11.017 15753013
14. Human papillomavirus types in head and neck squamous cell carcinomas worldwide: a systematic review. AR Kreimer GM Clifford P Boyle S Franceschi, Cancer Epidemiol Biomarkers Prev 2005 14 467 475 10.1158/1055-9965.EPI-04-0551 15734974 (Pubitemid 40270113)
15. Human papillomavirus type 26-associated periungual squamous cell carcinoma in situ in a HIV-infected patient with concomitant penile and anal intraepithelial neoplasia. A Kreuter NH Brockmeyer H Pfister P Altmeyer U Wieland, J Am Acad Dermatol 2005 53 737 739 10.1016/j.jaad.2005.03.022 16198810 (Pubitemid 41399958)
16. Two novel genital human papillomavirus (HPV) types, HPV68 and HPV70, related to the potentially oncogenic HPV39. M Longuet S Beaudenon G Orth, J Clin Microbiol 1996 34 738 744 8904450 (Pubitemid 26065811)
17. Distribution and viral load of eight oncogenic types of human papillomavirus (HPV) and HPV 16 integration status in cervical intraepithelial neoplasia and carcinoma. M Guo N Sneige EG Silva YJ Jan DE Cogdell E Lin R Luthra W Zhang, Mod Pathol 2007 20 256 266 10.1038/modpathol.3800737 17192787 (Pubitemid 46422181)
18. Human papillomavirus type 16 and 18 gene expression in cervical neoplasias. MH Stoler CR Rhodes A Whitbeck SM Wolinsky LT Chow TR Broker, Hum Pathol 1992 23 117 128 10.1016/0046-8177(92)90232-R 1310950
19. Use of multiple PCR primer sets for optimal detection of human papillomavirus. F Karlsen M Kalantari A Jenkins E Pettersen G Kristensen R Holm B Johansson B Hagmar, J Clin Microbiol 1996 34 2095 2100 8862564 (Pubitemid 26272183)
20. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. JM Walboomers MV Jacobs MM Manos FX Bosch JA Kummer KV Shah PJ Snijders J Peto CJ Meijer N Munoz, J Pathol 1999 189 12 19 10.1002/(SICI)1096- 9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F 10451482 (Pubitemid 29406813)
21. Sequence variation and physical state of human papillomavirus type 16 cervical cancer isolates from Australia and New Caledonia. KJ Watts CH Thompson YE Cossart BR Rose, Int J Cancer 2002 97 868 874 10.1002/ijc.10103 11857370 (Pubitemid 34106347)
22. Analysis of integrated human papillomavirus type 16 DNA in cervical cancers: amplification of viral sequences together with cellular flanking sequences. M Wagatsuma K Hashimoto T Matsukura, J Virol 1990 64 813 821 2153245 (Pubitemid 20032698)
23. Abundance of multiple high-risk human papillomavirus (HPV) infections found in cervical cells analyzed by use of an ultrasensitive HPV genotyping assay. M Schmitt B Dondog T Waterboer M Pawlita M Tommasino T Gheit, J Clin Microbiol 2010 48 143 149 10.1128/JCM.00991-09 19864475
24. Human papillomavirus and Papanicolaou tests to screen for cervical cancer. P Naucler W Ryd S Tornberg A Strand G Wadell K Elfgren T Radberg B Strander B Johansson O Forslund BG Hansson E Rylander J Dillner, N Engl J Med 2007 357 1589 1597 10.1056/NEJMoa073204 17942872 (Pubitemid 47598401)
25. Molecular screening for cervical cancer - time to give up Pap tests? CD Runowicz, N Engl J Med 2007 357 1650 1653 10.1056/NEJMe078155 17942878 (Pubitemid 47598409)
26. The natural history of human papillomavirus infection and cervical intraepithelial neoplasia among young women in the Guanacaste cohort shortly after initiation of sexual life. AC Rodriguez R Burk R Herrero A Hildesheim C Bratti ME Sherman D Solomon D Guillen M Alfaro R Viscidi J Morales M Hutchinson S Wacholder M Schiffman, Sex Transm Dis 2007 34 494 502 17237737 (Pubitemid 46987958)
27. Human papillomavirus DNA versus Papanicolaou screening tests for cervical cancer. MH Mayrand E Duarte-Franco I Rodrigues SD Walter J Hanley A Ferenczy S Ratnam F Coutlee EL Franco, N Engl J Med 2007 357 1579 1588 10.1056/NEJMoa071430 17942871 (Pubitemid 47598400)
28. HPV screening for cervical cancer in rural India. R Sankaranarayanan BM Nene SS Shastri K Jayant R Muwonge AM Budukh S Hingmire SG Malvi R Thorat A Kothari R Chinoy R Kelkar S Kane S Desai VR Keskar R Rajeshwarkar N Panse KA Dinshaw, N Engl J Med 2009 360 1385 1394 10.1056/NEJMoa0808516 19339719
29. The clinical relevance of human papillomavirus testing: relationship between analytical and clinical sensitivity. PJ Snijders AJ van den Brule CJ Meijer, J Pathol 2003 201 1 6 10.1002/path.1433 12950011 (Pubitemid 37121197)